New Osteoporosis Drug (SERM) Closer to Market
Wyeth is moving forward with its new drug to combat osteoporosis in post-menopausal women. The FDA has issued a second "approvable letter" for bazedoxifene. The pharmeceutical company must answer additional questions on incidence of stroke and blood clots and provide more documents to the agency before approval. The drug is a SERM... Read more


















